Shanghai Medicilon Inc
SSE:688202
Shanghai Medicilon Inc
Revenue
Shanghai Medicilon Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Medicilon Inc
SSE:688202
|
Revenue
¥1.7B
|
CAGR 3-Years
55%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Revenue
¥40.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Revenue
¥11.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Revenue
¥17B
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Revenue
¥7.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
36%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Revenue
¥4.2B
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Medicilon Inc's Revenue?
Revenue
1.7B
CNY
Based on the financial report for Dec 31, 2022, Shanghai Medicilon Inc's Revenue amounts to 1.7B CNY.
What is Shanghai Medicilon Inc's Revenue growth rate?
Revenue CAGR 5Y
46%
Over the last year, the Revenue growth was 42%. The average annual Revenue growth rates for Shanghai Medicilon Inc have been 55% over the past three years , 46% over the past five years .